Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARaα and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor

Journal of Endocrinology

Volumn 205, Issue 1, 2010, Pages 37-47

  Teillon, Sarah ^a   Calderon, German A ^a   Rios, Maribel ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DYSLIPIDEMIA; FEEDING; FEMALE; FOOD INTAKE; GENE; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID DIET; LIVER; LIVER DISEASE; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WILD TYPE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; DIETARY FATS; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FEMALE; FIBROBLAST GROWTH FACTORS; HYPERGLYCEMIA; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PPAR ALPHA; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 77949508276     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0405     Document Type: Article

References (51)

1. Adams LA, Feldstein A, Lindor KD & Angulo P 2004 Nonalcoholic fatty liverdisease among patients with hypothalamic and pituitary dysfunction. Hepatology 39 909-914.
2. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, Cavallo MG, Zalunardo B, Lirussi F, Alessandri C et al. 2005 Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. Journal of Clinical Endocrinology and Metabolism 90 1578-1582.
3. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS & Maratos-Flier E 2007 Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism 5 426-437.
4. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen RH, Howard MJ, Arends JJ, Desantis P, Coleman T & Semenkovich CF 2007 An afferent vagal nerve pathway links hepatic PPARα activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metabolism 5 91-102.
5. Bjorntorp P 1996 The regulation of adipose tissue distribution in humans. International Journal of Obesity and Related Metabolic Disorders 20 291-302.
6. Blaak E 2001 Gender differences in fat metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 4 499-502.
7. Browning JD & Horton JD 2004 Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation 114 147-152.
8. Cassiman D, Denef C, Desmet VJ & Roskams T 2001 Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 33 148-158.
9. Chen Y, Yang Y, Miller ML, Shen D, Shertzer HG, Stringer KF, Wang B, Schneider SN, Nebert DW & Dalton TP 2007 Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology 45 1118-1128.
10. Dostalova I, Haluzikova D & Haluzik M 2009 Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus. Physiological Research 58 1-7.
11. Ernfors P, Merlio JP & Persson H 1992 Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. European Journal of Neuroscience 4 1140-1158.
12. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF & Silverstein RL 1999 A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. Journal of Biological Chemistry 274 19055-19062.
13. Festi D, Colecchia A, Sacco T, Bondi M, Roda E & Marchesini G 2004 Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obesity Reviews 5 27-42.
14. Garcia-Suarez O, Gonzalez-Martinez T, Perez-Perez M, Germana A, Blanco-Gelaz MA, Monjil DF, Ciriaco E, Silos-Santiago I & Vega JA 2006 Expression of the neurotrophin receptor TrkB in the mouse liver. Anatomy and Embryology 211 465-473.
15. Kernie SG, Liebl DJ & Parada LF 2000 BDNF regulates eating behavior and locomotor activity in mice. EMBO Journal 19 1290-1300.
16. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA et al. 2005 FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation 115 1627-1635.
17. Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB & Etgen GJ 2007 The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148 774-781.
18. Kokkotou E, Jeon JY, Wang X, Marino FE, Carlson M, Trombly DJ & Maratos-Flier E 2005 Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 289 R117-R124.
19. Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, Vance DE & Dyck JR 2007 Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 56 2863-2871.
20. Langhans W 2003 Role of the liver in the control of glucose-lipid utilization and body weight. Current Opinion in Clinical Nutrition and Metabolic Care 6 449-455.]
21. Legato MJ 1997 Gender-specific aspects of obesity. International Journal of Fertility and Women's Medicine 42 184-197.
22. Lewin GR & Barde YA 1996 Physiology of the neurotrophins. Annual Review of Neuroscience 19 289-317.
23. Liang H, Balas B, Tantiwong P, Dube J, Goodpaster BH, O'Doherty RM, DeFronzo RA, Richardson A, Musi N & Ward WF 2009 Whole body overexpression of PGC-1a has opposite effects on hepatic and muscle insulin sensitivity. American Journal of Physiology. Endocrinology and Metabolism 296 E945-E954.
24. Lommatzsch M, Braun A, Mannsfeldt A, Botchkarev VA, Botchkareva NV, Paus R, Fischer A, Lewin GR & Renz H 1999 Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived neurotrophic functions. American Journal of Pathology 155 1183-1193.
25. Lundasen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE & Rudling M 2007 PPARa is a key regulator of hepatic FGF21. Biochemical and Biophysical Research Communications 360 437-440.
26. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE & Tessarollo L 1999 Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. PNAS 96 15239-15244.
27. McAllister AK, Katz LC & Lo DC 1999 Neurotrophins and synaptic plasticity. Annual Review of Neuroscience 22 295-318.
28. Mousavi K & Jasmin BJ 2006 BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. Journal of Neuroscience 26 5739-5749.
29. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Faga E, Silli B & Pagano G 2003 Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37 909-916.
30. Park SY, Cho YR, Kim HJ, Higashimori T, Danton C, Lee MK, Dey A, Rothermel B, Kim YB, Kalinowski A et al. 2005a Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54 3530-3540.
31. Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ, Cline G, Li H, Prentki M, Shulman GI et al. 2005b Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. American Journal of Physiology. Endocrinology and Metabolism 289 E30-E39.
32. Postic C & Magnuson MA 2000 DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26 149-150.
33. Priego T, Sanchez J, Pico C & Palou A 2008 Sex-differential expression of metabolism-related genes in response to a high-fat diet. Obesity 16 819-826.
34. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X & Li X 2009 Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metabolism 9 327-338.
35. Regitz-Zagrosek V, Lehmkuhl E &Weickert MO 2006 Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology 95 136-147.
36. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM & Jaenisch R 2001 Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Molecular Endocrinology 15 1748-1757.
37. Soriano P 1999 Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genetics 21 70-71.
38. Spandidos A, Wang X, Wang H, Dragnev S, Thurber T & Seed B 2008 A comprehensive collection of experimentally validated primers for polymerase chain reaction quantitation of murine transcript abundance. BMC Genomics 9 633.
39. Stienstra R, Duval C, Muller M & Kersten S 2007 PPARs, obesity, and inflammation. PPAR Research 2007 95974.
40. Stiles B,Wang Y, Stahl A, Bassilian S, LeeWP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA et al. 2004 Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity (corrected). PNAS 101 2082-2087.
41. Thorens B & Larsen PJ 2004 Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Current Opinion in Clinical Nutrition and Metabolic Care 7 471-478.
42. Tonra JR, Ono M, Liu X, Garcia K, Jackson C, Yancopoulos GD,Wiegand SJ &Wong V 1999 Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/ lepr(db) mice. Diabetes 48 588-594.
43. Tsuchida A, Nakagawa T, Itakura Y, Ichihara J, OgawaW,Kasuga M, TaijiM& NoguchiH2001 The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia 44 555-566.
44. Ukropec J, Penesova A, Skopkova M, Pura M, Vlcek M, Radikova Z, Imrich R, Ukropcova B, Tajtakova M, Koska J et al. 2008 Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements. Journal of Clinical Endocrinology and Metabolism 93 2255-2262.
45. Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M & Rios M 2007 Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. Journal of Neuroscience 27 14265-14274.
46. Wallace DF, Summerville L & Subramaniam VN 2007 Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. Gastroenterology 132 301-310.
47. Wang X & Seed B 2003 A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Research 31 e154.
48. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH & Reichardt LF 2003 Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience 6 736-742.
49. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, Xu JY, Chen B, Chow WS, Tso AWet al. 2005 Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. PNAS 102 6086-6091.
50. Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA et al. 2009 Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58 250-259.
51. Zhuo H, Sinclair C & Helke CJ 1994 Plasticity of tyrosine hydroxylase and vasoactive intestinal peptide messenger RNAs in visceral afferent neurons of the nodose ganglion upon axotomy-induced deafferentation. Neuroscience 63 617-626.